HBRM

 
Common Stock Alternative Reporting
Pink Current Information
 

OTC Disclosure & News Service

 

Herborium Signs the Distribution Agreement with Amazon Super Seller. Sales commenced in May 2017

May 17, 2017

OTC Disclosure & News Service

Fort Lee, NJ -

Fort Lee, N.J. May 17, 2017: Herborium® Group, Inc. (OTC Pink: HBRM),  www.Herborium.com, a Botanical Therapeutics® Company and the provider of unique all botanical medicinal products (Botanical Therapeutics®) that target dermatological issues such as acne, and other health and wellness concerns, announced today that it signed a Distribution Agreement with Amazon Super-Seller, Golden Team Synergy of California to distribute Herboriums unique Botanical Therapeutic®  for acne --AcnEase®. 

AcnEase has been successfully sold on Amazon since 2010 and had achieved a significant increase in revenues, number of orders and average value of the order. The increase in the average value of the order is especially significant since it indicates a growing consumer confidence in Herborium and its products. The average order value of AcnEase on Amazon increased 33% while the number of orders grew 113% since 2014.

The overall growth in revenues, increase in number of customers and the average order value for Amazon based sales has been a pivotal factor in Herborium s decision to partner with Amazon Golden Team Synergy that is one of the most prominent and successful Amazon Super-Seller  with interest to  expending their natural wellness and beauty product base.

According to e-Marketer (August 2016) worldwide retail e commerce reached over 1.9 trillion dollars in 2016 and is expected to reach $4 Trillion in 2020. 2016 retail ecommerce sales in North America rise 15.6% this year to reach $423.34 billion, maintaining the areas status as the worlds second largest regional ecommerce market after Asia. Amazon sales alone for 2016 reached impressive $136 million  

AcnEase provides a total solution for acne sufferers. The 100% botanical, proprietary treatment has a 96% user success rate, and is free of chemicals, hormones, preservatives, gluten, dairy, sugar and GMOs.  While providing a uniquely, efficacious and safe product supported by clinical data, the brand is also focused on providing results-driven, life-changing content such as cutting edge educational information on acne, its treatment options, safety related issues, as well as tips for every day and special situation skincare

In April 2017 AcnEase® skincare treatment blog (http://www.acnease.com/acne-treatment-blog/) has been named, the Best Skincare Blog of 2017 by the distinguished Healthline.com.  The AcnEase blog was selected by Healthline to join the exclusive list of winners for the 3rd year in a row (2015, 2016 and 2017) and praised as one of the most up-to-date, informative, and inspiring blogs that aim to uplift their readers through education and personal stories. http://www.healthline.com/health/best-skin-care-blogs

There are over 60 million people in the US alone who suffer from acne and who need real help and support.  Over 75% of all individuals will have acne at the certain period of their life, and the average age of an acne sufferer today is 26.5, which negates the myth that acne is a teen problem that goes away on its own.  

The new distribution arrangements and partnership with Amazon Super Seller distinguished for its successful and ethical business practices is another example of Herboriums aggressive Road-To-Market with the ultimate and ambitious goal to eventually capture 1% of the Global Natural Treatments and Beauty Market. 

 About Herborium Group, Inc.

Herborium Group, Inc. is a Botanical Therapeutics® company that develops, licenses and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The Companys business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements).  The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products (FDA Guidance 2004) to establish and maintain a differential advantage.  Herborium has secured a pipeline of botanical ingredients based products in the areas of dermatological needs, wellness and energy, prostate health, womens health and selected sexual disorders resulting from cardiovascular disease, use of anti-depressants, diabetes, surgical procedures, and other issues. Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce. For more information, please visit www.herborium.com, www.acnease.com, www.acnease.fr.www.acneasesp.com, www.acnease.co.uk.   

Safe Harbor Statement:  This release contains forward-looking statements with respect to the results of operations and business of Herborium Group, Inc., which involves risks and uncertainties.  The Company's actual future results could materially differ from those discussed.   The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.

Contact Information:

Herborium Group, Inc.

Email: InvestorsRelations@Herborium.com or DrAgnes@Herborium.com

 


This release includes additional documents. Select the link(s) below to view.

PR Amazon Super seller April 2017 1.pdf

Copyright © 2017 OTC Markets. All Rights Reserved


The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.